Walpar Nutritions
Ticker > Company >

Walpar Nutritions share price

Walpar Nutritions Ltd.

NSE: WALPAR SECTOR: Pharmaceuticals & Drugs  11k   7   0

50.00
0 0
NSE: 26 Dec 03:31 PM

Price Summary

Today's High

₹ 50

Today's Low

₹ 50

52 Week High

₹ 76.98

52 Week Low

₹ 39

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 46.95 Cr.

Enterprise Value

₹ 46.82 Cr.

No. of Shares

0.94 Cr.

P/E

42.22

P/B

2.61

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  19.18

CASH

₹ 0.45 Cr.

DEBT

₹ 0.32 Cr.

Promoter Holding

68.44 %

EPS (TTM)

₹  1.18

Sales Growth

78.77%

ROE

9.03 %

ROCE

11.98%

Profit Growth

277.61 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year78.77%
3 Year103.73%
5 YearNA

Profit Growth

1 Year277.61%
3 Year94.64%
5 YearNA

ROE%

1 Year9.03%
3 Year5.68%

ROCE %

1 Year11.98%
3 Year7.93%

Debt/Equity

0.0237

Price to Cash Flow

14.98

Interest Cover Ratio

8.188

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 68.44 0.00
Mar 2024 71.23 0.00
Sep 2023 71.46 0.00
Mar 2023 70.54 0.00
Sep 2022 70.58 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 103.733764408963% for the Past 3 years.
  • The company has significantly decreased its debt by 2.8895 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 8.188.
  • Company’s PEG ratio is 0.159206795978222.
  • The company has an efficient Cash Conversion Cycle of 46.2991 days.
  • The company has a high promoter holding of 68.44%.

 Limitations

  • Company has a poor ROE of 5.6828% over the past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high PE of 42.22.

Quarterly Result (All Figures in Cr.)
Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 6.07 26.76 28.7 51.31
Total Expenditure 5.61 25.7 27.92 49.55
Operating Profit 0.46 1.06 0.78 1.76
Other Income 0 0.04 0.27 0.13
Interest 0.18 0.48 0.34 0.21
Depreciation 0.12 0.28 0.25 0.21
Exceptional Items 0 0 0 0
Profit Before Tax 0.16 0.34 0.46 1.48
Tax 0.01 -0.08 0.16 0.37
Net Profit 0.15 0.42 0.29 1.11
Adjusted EPS (Rs.) 0.23 0.46 0.32 1.18

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 3.34 4.54 4.54 4.7
Total Reserves 1.44 6.49 6.78 8.64
Borrowings 2.63 1.6 1.03 0
Other N/C liabilities -0.04 -0.21 -0.16 -0.12
Current liabilities 8.29 10.72 9.51 10.16
Total Liabilities 15.66 23.15 21.7 23.38
Assets
Net Block 1.07 0.94 0.83 1.48
Capital WIP 0 0 0.02 0.02
Intangible WIP 0 0 0 0
Investments 0.06 2.93 2.84 4.7
Loans & Advances 0.6 2.32 1.81 0.03
Other N/C Assets 0.2 0.04 0.03 0.02
Current Assets 13.73 16.91 16.17 17.12
Total Assets 15.66 23.15 21.7 23.38
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.16 0.34 0.46 1.48
Adjustment 0.3 0.76 0.59 0.35
Changes in Assets & Liabilities 0.92 -1.34 0.12 1.42
Tax Paid 0 -0.07 -0.08 -0.11
Operating Cash Flow 1.38 -0.32 1.09 3.13
Investing Cash Flow -0.7 -4.58 0.46 -0.88
Financing Cash Flow -0.06 4.27 -1.52 -2.18
Net Cash Flow 0.62 -0.63 0.03 0.07

Corporate Actions

Investors Details

PARTICULARS Sep 2022% Mar 2023% Sep 2023% Mar 2024% Sep 2024%
promoters 70.58 70.54 71.46 71.23 68.44
abhishekkumar dineshkumar... 2.97 2.97 2.88 2.88 2.88
amit vishnubhai patel 0.11 0.11 0.11 0.11 0.11
arunaben s raval 0.04 0.04 0.04 0.04 0.04
ashwin r shah 0.09 0.09 0.09 0.09 0.09
dineshkumar kantilal modi... 0.04 0.04 0.04 0.04 0.02
divyanshu subhashchandra ... 2.97 2.97 2.88 2.79 2.24
fenil prakashkumar shah 1.32 1.32 1.28 1.28 1.28
jignaben prakashkumar sha... 0.11 0.11 0.11 0.06 0.06
jigneshkumar dineshkumar ... 2.97 2.97 2.88 2.88 2.88
kalpesh pravinchandra lad... 17.18 17.18 18.36 18.36 18.36
kanan dipak shah 0.04 0.04 0.04 0.04 0.04
krunal jasubhai patel 3.72 3.72 4.03 4.03 4.03
naresh ramanlal shah 0.04 0.04 0.04 0.04 0.04
nidhi yogeshkumar shah 6.47 6.47 6.26 6.26 6.26
palakben hirenkumar shah 0.11 0.11 0.11 0.11 0.11
patel kashyap vishnubhai 0.11 0.11 0.11 0.11 0.11
payal krunalkumar patel 0.07 0.11 0.11 0.07 0.07
pragneshkumar natvarlal s... 0.11 0.11 0.11 0.11 0.11
pravinchandra narsinhlal ... 0.44 0.44 0.43 0.43 0.43
ravi g shah 0.04 0.04 0.04 0.04 0.04
ripal kanubhai patel 0.22 0.22 0.21 0.21 0.21
sejal kalpesh ladhawala 15.50 15.50 16.10 16.10 14.65
shah rakesh narharilal 0.44 0.44 0.43 0.43 0.43
tanmaykumar ashwinbhai sh... 14.53 14.53 14.06 14.06 13.31
tejal vijaykumar thakkar 0.33 0.33 0.32 0.28 0.28
vijay thakkar 0.33 0.33 0.32 0.32 0.32
yogesh ghanshyambhai shah... 0.07 0.07 0.06 0.06 0.06
dilipkumar natvarlal pate... 0.02 0.02 0.02 0.02 -
ladhawala rushi narsinhla... 0.02 0.02 0.02 - -
jashavantkumar premshanka... 0.04 0.04 - - -
kartik jagdishchandra mod... 0.09 - - - -
PARTICULARS Sep 2022% Mar 2023% Sep 2023% Mar 2024% Sep 2024%
investors 29.42 29.46 28.54 28.77 31.56
bijay pratap singh huf - - 1.53 1.49 1.45
champaklal amratlal shah 1.37 1.37 1.32 1.32 1.32
dakshaben ashvinkumar sha... 1.54 1.54 1.49 1.49 1.49
rajesh kumar 1.63 1.94 2.90 2.64 1.15
shri bajrangbali ashok co... - - - - 1.15
xtended business reportin... 1.72 1.81 1.75 2.22 2.22

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Walpar Nutritions Stock Price Analysis and Quick Research Report. Is Walpar Nutritions an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Walpar Nutritions and its performance over the period of time. Walpar Nutritions stock price today is Rs 50.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Walpar Nutritions cash from the operating activity was Rs 3.1348 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Walpar Nutritions has a Debt to Equity ratio of 0.0237 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Walpar Nutritions , the EPS growth was 265.206 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Walpar Nutritions has OPM of 3.43277968433626 % which is a bad sign for profitability.
     
  • ROE: Walpar Nutritions have a poor ROE of 9.0348 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Walpar Nutritions is Rs 50. One can use valuation calculators of ticker to know if Walpar Nutritions share price is undervalued or overvalued.
Last Updated on:
Brief about Walpar Nutritions
X